Mesenchymal stem/stromal cells: dedicator to maintain tumor homeostasis
- PMID: 39607530
- DOI: 10.1007/s13577-024-01154-y
Mesenchymal stem/stromal cells: dedicator to maintain tumor homeostasis
Abstract
Mesenchymal stem/stromal cells (MSCs) act as a factor in tumor recurrence after drug treatment with their involvement observed in various cancer types. As a constituent of the tumor microenvironment (TME), MSCs not only provide support to tumor growth but also establish connections with diverse cell populations within the TME, serving as mediators linking different tumor-associated components. MSCs play an important role in maintaining tumor progression due to their stem cell properties and remarkable differentiation capacity. Given the intensification of tumor research and the encouraging results achieved in recent years,the aim of this article is to investigate the supportive role of MSCs in tumor cells as well as in various cellular and non-cellular components of the tumor microenvironment. Furthermore, the article shows that MSCs do not have a specific anatomical ecological niche and describes the contribution of MSCs to the maintenance of tumor homeostasis on the basis of homing, plasticity and tumor-forming properties. By elucidating the critical roles of different components of TME, this study provides a comprehensive understanding of tumor therapy and may offer new insights into defeating cancer.
Keywords: Epithelial–mesenchymal transition; Immunosuppression; Metastasis; Proliferation; Tumor microenvironment.
© 2024. The Author(s) under exclusive licence to Japan Human Cell Society.
Conflict of interest statement
Declarations. Conflict of interest: No funds, grants, or other support was received. Ethics approval: This is an observational study. The Jiangsu University Research Ethics Committee has confirmed that no ethical approval is required. Informed consent: Not applicable.
Similar articles
-
Mesenchymal Stem Cells in the Tumor Microenvironment.Adv Exp Med Biol. 2020;1234:31-42. doi: 10.1007/978-3-030-37184-5_3. Adv Exp Med Biol. 2020. PMID: 32040853 Review.
-
Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment.Stem Cells. 2022 Aug 25;40(8):705-715. doi: 10.1093/stmcls/sxac036. Stem Cells. 2022. PMID: 35583414 Free PMC article. Review.
-
Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches.Front Immunol. 2023 Nov 3;14:1280601. doi: 10.3389/fimmu.2023.1280601. eCollection 2023. Front Immunol. 2023. PMID: 38022534 Free PMC article. Review.
-
Mesenchymal Stromal Cells in Neuroblastoma: Exploring Crosstalk and Therapeutic Implications.Stem Cells Dev. 2021 Jan 15;30(2):59-78. doi: 10.1089/scd.2020.0142. Stem Cells Dev. 2021. PMID: 33287630 Free PMC article. Review.
-
The Multifunction Role of Tumor-Associated Mesenchymal Stem Cells and Their Interaction with Immune Cells in Breast Cancer.Immunol Invest. 2023 Nov;52(7):856-878. doi: 10.1080/08820139.2023.2249025. Epub 2023 Aug 24. Immunol Invest. 2023. PMID: 37615117 Review.
References
-
- Belli C, Trapani D, Viale G, et al. Targeting the microenvironment in solid tumors. Cancer Treat Rev. 2018. https://doi.org/10.1016/j.ctrv.2018.02.004 . - DOI - PubMed
-
- Borriello L, Nakata R, Sheard MA, et al. Cancer-associated fibroblasts share characteristics and protumorigenic activity with mesenchymal stromal cells. Cancer Res. 2017. https://doi.org/10.1158/0008-5472.Can-16-2586 . - DOI - PubMed - PMC
-
- Zhang F, Liu H, Duan M, et al. Crosstalk among m(6)A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application. J Hematol Oncol. 2022. https://doi.org/10.1186/s13045-022-01304-5 . - DOI - PubMed - PMC
-
- Guo KT, SchAfer R, Paul A, Gerber A, Ziemer G, Wendel HP. A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers. Stem Cells. 2006. https://doi.org/10.1634/stemcells.2006-0015 . - DOI - PubMed
-
- Stratford EW, Castro R, Wennerstrom A, et al. Liposarcoma cells with aldefluor and CD133 activity have a cancer stem cell potential. Clin Sarcoma Res. 2011. https://doi.org/10.1186/2045-3329-1-8 . - DOI - PubMed - PMC
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials